• Medcotec, a UK developer of powder transfer valves for pharmaceutical manufacturers, raised over £2.4 million to commercialize its technology.
• Mercia Ventures led the round through NPIF II - Mercia Equity Finance, alongside LYVA Labs, Liverpool City Region Seed Fund and private investors.
• The Daresbury-based company will use the funding for further trials and team expansion ahead of launching its single-use Helyx valve.
• LYVA Labs previously provided pre-seed investment in June 2025.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mercia Asset Management plc published the original content used to generate this news brief on October 16, 2026, and is solely responsible for the information contained therein.